James O McNamara Selected Research

James O McNamara Research Topics

Disease

10	Seizures (Absence Seizure) 12/2023 - 10/2002
10	Epilepsy (Aura) 11/2021 - 01/2008
8	Status Epilepticus (Complex Partial Status Epilepticus) 12/2021 - 01/2003
8	Neoplasms (Cancer) 09/2017 - 12/2005
5	Temporal Lobe Epilepsy 12/2023 - 07/2013
3	Neoplasm Metastasis (Metastasis) 09/2017 - 12/2005
2	Infections 11/2023 - 01/2014
2	Breast Neoplasms (Breast Cancer) 09/2017 - 07/2012
2	Febrile Seizures (Febrile Seizure) 12/2016 - 06/2015
2	Prostatic Neoplasms (Prostate Cancer) 09/2009 - 08/2006
1	Treatment-Resistant Depressive Disorder 01/2017
1	Partial Epilepsies (Epilepsy, Partial) 01/2017
1	Urinary Tract Infections (Urinary Tract Infection) 01/2017
1	Edema (Dropsy) 12/2016
1	Microcephaly 10/2013
1	Brain Diseases (Brain Disorder) 10/2013
1	Nervous System Diseases (Neurological Disorders) 10/2012
1	Juvenile Myoclonic Epilepsy 08/2012
1	Idiopathic Generalized Epilepsy 08/2012
1	Absence Epilepsy (Childhood Absence Epilepsy) 08/2012
1	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2002
1	Ischemia 10/2002

Drug/Important Bio-Agent (IBA)

4	Kainic Acid (Kainate)IBA 12/2021 - 01/2003
4	Proteins (Proteins, Gene)FDA Link 11/2021 - 02/2003
4	trkB ReceptorIBA 11/2015 - 01/2004
3	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2020 - 01/2004
3	Nucleotide AptamersIBA 07/2012 - 09/2009
2	fibroblast growth factor 13IBA 12/2016 - 06/2015
2	Neuroprotective AgentsIBA 11/2015 - 10/2012
2	RNA (Ribonucleic Acid)IBA 07/2012 - 09/2009
2	LigandsIBA 07/2012 - 10/2011
2	AntigensIBA 10/2011 - 09/2009
2	Small Interfering RNA (siRNA)IBA 09/2009 - 08/2006
2	Complement System Proteins (Complement)IBA 02/2003 - 10/2002
1	Micrococcal NucleaseIBA 11/2023
1	ProteomeIBA 11/2021
1	Biomarkers (Surrogate Marker)IBA 09/2017
1	Nucleic Acid ProbesIBA 09/2017
1	Deoxyribonuclease I (Nickase)IBA 01/2017
1	Oligonucleotide ProbesIBA 01/2017
1	Protein Isoforms (Isoforms)IBA 12/2016
1	Phospholipases (Phospholipase)IBA 11/2015
1	Peptides (Polypeptides)IBA 11/2015
1	tyrosine receptor (receptor, tyrosine)IBA 11/2015
1	Tamoxifen FDA LinkGeneric 08/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2014
1	EnzymesIBA 01/2014
1	Virulence Factors (Pathogenicity Factors)IBA 01/2014
1	Deoxyribonucleases (DNase)FDA Link 01/2014
1	Aspartate-Ammonia Ligase (Asparagine Synthetase)IBA 10/2013
1	Phosphotransferases (Kinase)IBA 07/2013
1	Immunoglobulin E (IgE)IBA 08/2012
1	NucleotidesIBA 08/2012
1	Cisplatin (Platino)FDA LinkGeneric 07/2012
1	Trastuzumab (Herceptin)FDA Link 07/2012
1	human ERBB2 proteinIBA 07/2012
1	AntibodiesIBA 10/2011
1	OligonucleotidesIBA 10/2011
1	Surface Antigens (Surface Antigen)IBA 10/2011
1	Green Fluorescent ProteinsIBA 01/2010
1	Pilocarpine (Ocusert)FDA LinkGeneric 01/2010
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 09/2009
1	Pentylenetetrazole (Metrazol)IBA 09/2008
1	N- (6- Chloropyridin- 3- yl)- 3,4- difluorobenzamideIBA 09/2008
1	Dihydrotachysterol (AT 10)IBA 09/2008
1	Potassium Channels (Potassium Channel)IBA 09/2008
1	BuffersIBA 10/2006
1	Excitatory Amino Acid AntagonistsIBA 10/2006
1	2-Amino-5-phosphonovalerate (2 Amino 5 phosphonovalerate)IBA 10/2006
1	Cell Surface ReceptorsIBA 08/2006
1	Indicators and Reagents (Reagents)IBA 08/2006
1	Integrin alphaVbeta3IBA 12/2005
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 02/2003
1	Semaphorins (Semaphorin)IBA 01/2003
1	Complementary DNA (cDNA)IBA 01/2003
1	Glutamate Receptors (Glutamate Receptor)IBA 10/2002

Therapy/Procedure

8	Therapeutics 12/2023 - 08/2006
2	Vagus Nerve Stimulation 01/2017 - 11/2012
2	Induced Hyperthermia (Thermotherapy) 12/2016 - 06/2015
1	Implanted Electrodes 12/2023
1	Drug Therapy (Chemotherapy) 07/2012